Latest market price
21.51
+0.16+0.75%
OverviewShort InterestFilings
AMRXQT71Amneal Pharmaceuticals, Inc.·NASDAQ
21.51+0.75%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 23, 20268-K/ACurrent report (amended)
Sep 21, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 03, 2026S-3ASRS-3ASR
Sep 02, 20264Statement of changes in beneficial ownership
Aug 25, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 13, 20264Statement of changes in beneficial ownership
Aug 13, 20264Statement of changes in beneficial ownership
Aug 13, 20264Statement of changes in beneficial ownership
Aug 12, 2026144Notice of proposed sale of restricted securities
Aug 12, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 12, 2026144Notice of proposed sale of restricted securities
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 12, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 11, 2026144Notice of proposed sale of restricted securities
Aug 10, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 03, 20268-KCurrent report
Jul 31, 20268-KCurrent report
Jul 30, 20268-KCurrent report
#1 / 25 of 380
Page
▼
/ 16